Phytophthora infestans. If the name doesn't ring a bell, the history might. This is the organism that caused the Irish Potato Famine in the 1840s, killing over a million people and forcing another million to emigrate. Nearly two centuries later, potato late blight still costs European farmers billions of euros annually. The primary weapon against it? Chemical fungicides, applied repeatedly throughout the growing season, at increasing cost and diminishing public acceptance.

A Copenhagen-area startup called Mycoverse thinks there's a better way. The company has raised EUR 2.4 million in pre-seed funding to develop biological crop protection using fungi, the very kingdom of organisms that includes the pathogen, to fight it. The round was co-led by Future Food Fund and HTGF (High-Tech Grunderfonds), with participation from PINC, the venture arm of Finnish food company Paulig.

Including earlier support from Denmark's BioInnovation Institute, Mycoverse has now raised roughly EUR 4.3 million in total. That's modest by tech standards but meaningful for a pre-revenue AgTech company working at the intersection of biology and machine learning.

The concept sounds almost poetic. Mycoverse's platform uses artificial intelligence to screen naturally occurring fungal strains for protective properties against crop diseases. Rather than engineering organisms in a lab, the company is scouring nature's existing library and using AI to identify which strains could work as biological shields.

The approach integrates into existing farming practices. Farmers wouldn't need new equipment or dramatically different spraying routines. Mycoverse's biological agents are designed to slot into the same application methods that farmers already use for chemical fungicides. That matters enormously for adoption. Agricultural technology has a long history of brilliant solutions that failed because they asked farmers to change too much.

The first target is potato late blight in Europe, but the pipeline extends to grapevines and potentially other high-value crops. Each new crop-pathogen combination requires its own screening and validation process, which is why the AI acceleration matters. Traditional biocontrol discovery can take a decade. Mycoverse claims its platform compresses that timeline significantly.

The EU's Farm to Fork Strategy calls for a 50 percent reduction in chemical pesticide use by 2030. That target has created both a regulatory push and a commercial pull for biological alternatives. Major agricultural chemical companies like BASF and Syngenta have been acquiring biocontrol companies and building their own portfolios. The market is moving.

Mycoverse's use of artificial intelligence deserves closer examination. The company isn't using AI to do something flashy. It's using it to solve a genuinely tedious bottleneck: screening thousands of fungal strains to find the handful that show protective activity against a specific pathogen.

In traditional biocontrol R&D, researchers might test a few hundred strains over several years. Mycoverse's platform can evaluate substantially more candidates by predicting which fungal characteristics correlate with protective function, then prioritizing the most promising candidates for laboratory and field testing. It's not replacing the biology. It's making the biology faster.

The risk, as with all biocontrol approaches, is that laboratory results don't always translate to field conditions. Soil ecosystems are complex. Temperature, humidity, microbial competition, and application timing all affect whether a biological agent works in practice. Mycoverse's funded field trials over the next two years will need to demonstrate that its AI-identified strains perform under commercial conditions, not just in controlled environments.

PINC, the venture arm of Finnish food company Paulig, joining the round adds an interesting dimension. Paulig processes food. It cares about supply chain resilience and the quality of raw ingredients. A food company investing in biological crop protection suggests that the demand signal isn't just coming from farmers looking to cut costs. It's coming from the food industry itself, which faces consumer pressure on pesticide residues and sustainability credentials.

That downstream pull could accelerate Mycoverse's path to commercialization. If food companies are willing to pay premiums for crops grown with biological rather than chemical protection, the economics for farmers shift. The biological product doesn't need to be cheaper than the chemical alternative. It just needs to be worth the premium the supply chain is willing to pay.

There's something genuinely compelling about using one branch of the fungal kingdom to defend crops against another. Phytophthora infestans reshaped world history. The chemical response has been effective but unsustainable. And now a Danish startup with EUR 4.3 million in funding is proposing that nature already contains the solution.

Whether Mycoverse's AI-accelerated discovery platform can deliver commercially viable products remains an open question. Pre-seed is early. Field trials are ahead. Regulatory approval processes for biological crop protection agents, while generally faster than for chemical pesticides, still take time. But the direction is clear, the investors are credible, and the market is moving. Sometimes that's enough to start something meaningful.